Back to top
more

Abbott Laboratories (ABT)

(Real Time Quote from BATS)

$110.93 USD

110.93
1,229,860

-0.01 (-0.01%)

Updated Aug 16, 2024 11:24 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (95 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Abbott (ABT) closed at $74.05 in the latest trading session, marking a +1.08% move from the prior day.

Abbott (ABT) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Abbott (ABT) closed at $68.53 in the latest trading session, marking a -0.77% move from the prior day.

Abbott (ABT) Up 3.8% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Abbott (ABT) Stock Moves -0.12%: What You Should Know

by Zacks Equity Research

Abbott (ABT) closed at $69.41 in the latest trading session, marking a -0.12% move from the prior day.

Surmodics' (SRDX) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Surmodics (SRDX) sees solid segmental performance in fiscal Q4; gains from alliance with Abbott.

Abbott (ABT) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, Abbott (ABT) closed at $72.96, marking a +0.63% move from the previous day.

Abbott (ABT) Q3 Earnings Top Estimates

by Zacks Equity Research

Abbott (ABT) delivered earnings and revenue surprises of 1.35% and -0.12%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Abbott (ABT) closed the most recent trading day at $69.30, moving +1.91% from the previous trading session.

Abbott (ABT) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Abbott (ABT) closed at $67.68 in the latest trading session, marking a +1.11% move from the prior day.

DexCom Launches CLARITY Mobile App, Strengthens CGM Profile

by Zacks Equity Research

DexCom (DXCM) benefits from the diabetes care space as it adopts cloud-based services for Continuous Glucose Monitoring.

    Abbott (ABT) Q3 Earnings Top Estimates, Guidance Narrowed

    by Zacks Equity Research

    Within Structural Heart, growth was driven by several product areas across Abbott's (ABT) broad portfolio, including AMPLATZER PFO Occluder and MitraClip.

    Ryan McQueeney headshot

    Bank Stocks Earnings Scorecard, Fed Minutes, & Trade Talks on "Hiatus"

    by Ryan McQueeney

    Ryan McQueeney discusses the upcoming Fed minutes and Wilbur Ross' comments about U.S.-China trade talks. He also recaps earnings reports from United, Abbot Labs, and U.S. Bancorp. Later, he takes at a look at the earnings scorecard for bank stocks.

    Earnings & Economic Data Deluge

    by Zacks Equity Research

    Earnings & Economic Data Deluge

    Mark Vickery headshot

    Q3 Earnings Stay (Mostly) Strong, Plus Housing Data

    by Mark Vickery

    With new Housing Starts, Building Permits and Mortgage Application data, we continue to collect new Q3 earnings results, particularly from UAL, ABT and USB.

    Abbott (ABT) Q3 Earnings Top Estimates

    by Zacks Equity Research

    Abbott (ABT) delivered earnings and revenue surprises of 1.35% and -0.12%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

    Tracey Ryniec headshot

    5 Earnings Charts in the Spotlight

    by Tracey Ryniec

    Want to know what's going on in the global economy? Check in with these five companies reporting earnings this week.

    Can Abbott's (ABT) Steady Overall Growth Aid Q3 Earnings?

    by Zacks Equity Research

    Abbott (ABT) is consistently well-placed on a healthy growth trajectory within its Diabetes Care business for the past few quarters.

    Why Abbott Laboratories (ABT) Might Surprise This Earnings Season

    by Zacks Equity Research

    Abbott Laboratories (ABT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

    Abbott (ABT) Gains But Lags Market: What You Should Know

    by Zacks Equity Research

    Abbott (ABT) closed the most recent trading day at $69.33, moving +1.39% from the previous trading session.

    Abbott (ABT) Q3 Earnings Preview: How Are Events Shaping Up?

    by Zacks Equity Research

    Abbott (ABT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Mark Vickery headshot

    Top Stock Reports for Apple, Microsoft & Pfizer

    by Mark Vickery

    Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Microsoft (MSFT) and Pfizer (PFE).

    Will Walgreens (WBA) Q4 Earnings Gain From Overall Strength?

    by Zacks Equity Research

    Several planned developments, early benefits of new pharmacy contracts as well as an increase in volume are consistently driving growth within Walgreens Boots' (WBA) Retail Pharmacy USA division.

      Sreyoshi Mukherjee headshot

      US Diabetes Market Gaining Momentum: 3 Stocks in Focus

      by Sreyoshi Mukherjee

      A rising geriatric population and lifestyle disorders are expanding the U.S. diabetic population.

        Abbott's CE Mark for FreeStyle Libre 2 Boosts Diabetes Arm

        by Zacks Equity Research

        Abbott (ABT) focuses on boosting diabetes care. The latest CE Mark will increase the top-line contributions from the Diabetes unit.

          Abbott's Troponin-I Wins CE Mark, Vascular Arm Gets a Revamp

          by Zacks Equity Research

          Abbott's (ABT) life-changing High Sensitive Troponin-I test uses a biomarker, specific to the heart.